Gabriel T Sayer
Overview
Explore the profile of Gabriel T Sayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Carey M, Ladanyi A, Nishikawa M, Bordon A, Leb J, Pinsino A, et al.
Artif Organs
. 2024 Aug;
48(12):1494-1501.
PMID: 39096053
Background: Pre-left ventricular assist device (LVAD) pectoralis muscle assessment, an estimate of sarcopenia, has been associated with postoperative mortality and gastrointestinal bleeding, though its association with inflammation, endotoxemia, length-of-stay (LOS),...
12.
Pinsino A, Jennings D, Ladanyi A, Duong P, Sweat A, Mahoney I, et al.
J Heart Lung Transplant
. 2024 Jul;
43(12):1963-1972.
PMID: 39069163
Background: Among heart transplantation (HT) recipients, the accuracy of serum creatinine (sCr)-based estimated glomerular filtration rate (eGFR) may be limited by fluctuations in muscle mass. Cystatin C (cysC) is less...
13.
Moeller C, Rubinstein G, Oren D, Fernandez Valledor A, Lotan D, Raikhelkar J, et al.
J Thorac Cardiovasc Surg
. 2024 Jul;
169(2):650-657.e4.
PMID: 39023496
Objective: The HeartMate 3 survival risk score was recently validated in the Multicenter study Of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 to predict patient-specific...
14.
Fernandez Valledor A, Moeller C, Rubinstein G, Rahman S, Oren D, Baranowska J, et al.
medRxiv
. 2024 Jul;
PMID: 38978641
Objectives: To evaluate the clinical implications of adjunctive molecular gene expression analysis (MMDx ) of biopsy specimens in heart transplant (HT ) recipients with suspected rejection. Introduction: Histopathological evaluation remains...
15.
Shih H, Mondellini G, Kurlansky P, Sun J, Ning Y, Feldman V, et al.
Artif Organs
. 2024 Jun;
48(9):1049-1059.
PMID: 38825957
Background: Hospital readmissions following left ventricular assist device (LVAD) remain a frequent comorbidity, associated with decreased quality of life and increased resources utilization. This study sought to determine causes, predictors,...
16.
Hynds M, Hayashi H, Kurlansky P, Zhao Y, Vinogradsky A, Yuzefpolskaya M, et al.
J Thorac Cardiovasc Surg
. 2024 May;
PMID: 38802043
Objective: To analyze the development of aortic insufficiency in patients who received central aortic valve repair when undergoing continuous-flow left ventricular assist device implantation. Methods: We conducted a retrospective review...
17.
Yuzefpolskaya M, Bohn B, Ladanyi A, Pinsino A, Braghieri L, Carey M, et al.
J Heart Lung Transplant
. 2024 May;
43(9):1395-1408.
PMID: 38744352
Background: Sarcopenia, characterized by loss of muscle mass and function, is prevalent in heart failure (HF) and predicts poor outcomes. We investigated alterations in sarcopenia index (SI), a surrogate for...
18.
Rubinstein G, Moeller C, Lotan D, Slomovich S, Fernandez-Valledor A, Oren D, et al.
ASAIO J
. 2024 Feb;
70(8):641-650.
PMID: 38373176
In patients supported by the HeartMate 3 left ventricular assist device (HM3 LVAD), pump speed adjustments may improve hemodynamics. We investigated the hemodynamic implications of speed adjustments in HM3 recipients...
19.
Fernandez Valledor A, Rubinstein G, Moeller C, Lorenzatti D, Rahman S, Lee C, et al.
J Heart Lung Transplant
. 2024 Feb;
43(6):1010-1020.
PMID: 38360159
Heart transplantation remains the gold standard treatment for end-stage heart failure patients without contraindications. However, limited donor availability and long wait times have created a need for left ventricular assist...
20.
Moeller C, Fernandez Valledor A, Oren D, Rubinstein G, Sayer G, Uriel N
Prog Cardiovasc Dis
. 2024 Jan;
82:135-146.
PMID: 38242192
This comprehensive review highlights the significant advancements in Left Ventricular Assist Device (LVAD) therapy, emphasizing its evolution from the early pulsatile flow systems to the cutting-edge continuous-flow devices, particularly the...